Mood disorders medications: Predictors of nonadherence - Review of the current literature

Expert Review of Neurotherapeutics

Volumn 13, Issue 7, 2013, Pages 809-825

  Pompili, Maurizio ^a   Venturini, Paola ^a   Palermo, Mario ^a   Stefani, Henry ^a   Seretti, Maria Elena ^a   Lamis, Dorian A ^b   Serafini, Gianluca ^a   Amore, Mario ^c   Girardi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Medication nonadherence; Mood disorders; Predictors; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; PAROXETINE; VENLAFAXINE;

AGE DISTRIBUTION; ALCOHOL ABUSE; ANTICHOLINERGIC EFFECT; ANXIETY; AWARENESS; BIPOLAR I DISORDER; BOREDOM; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DSM-IV; ETHNICITY; FUNCTIONAL DISEASE; GOOD CLINICAL PRACTICE; HEALTH BELIEF; HEALTH CARE PERSONNEL; HOMELESSNESS; HUMAN; INTROSPECTION; KNOWLEDGE; LOCUS OF CONTROL; MEDICATION COMPLIANCE; MEMORY DISORDER; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; PERSONALITY DISORDER; PRESCRIPTION; PREVALENCE; REVIEW; RURAL AREA; SENSATION SEEKING; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SUBSTANCE ABUSE; WEIGHT GAIN;

ADULT; HUMANS; MEDICATION ADHERENCE; MOOD DISORDERS;

EID: 84883151199     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2013.811976     Document Type: Review

References (89)

1. Colom F, Vieta E, Tacchi MJ, Sánchez- Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 7(Suppl. 5), 24-31 (2005).
2. Pompili M, Serafini G, Del Casale A et al. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Expert Rev. Neurother. 9(7), 985-1004 (2009).
3. Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am. J. Psychiatry 159(6), 909-916 (2002).
4. WHO, Geneva. Adherence to Long-Term Therapies: Evidence for Action. WHO, Geneva, Switzerland (2003).
5. National Institute of Mental Health. The Numbers Count: Mental Disorders in America. NIH, MD, USA (2008).
6. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 617-627 (2005).
7. US Census Bureau Population Estimates by Demographic Characteristics. Table 2: Annual Estimates of the Population by Selected Age Groups and Sex For The United States: April 1, 2000 to July 1, 2004. (NC-EST 2004-02). US Census Bureau, Washington, DC, USA (2005)
8. World Health Organization. The World Health Report 2004: Changing History, Annex Table 3: Burden of Disease in DAYLYs by Cause, Sex and Mortality Statum in WHO Regions, Estimates for 2002. WHO, Geneva, Switzerland (2004).
9. O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 166(17), 1802-1804 (2006).
10. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr. Scand. 101(2), 119-124 (2000).
11. Hou R, Cleak V, Peveler R. Do treatment and illness beliefs influence adherence to medication in patients with bipolar affective disorder? A preliminary crosssectional study. Eur. Psychiatry 25(4), 216-219 (2010).
12. González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry 43(7), 263-270 (2010).
13. Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Res. 190(1), 110-114 (2011).
14. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr. Scand. 105(3), 164-172 (2002).
15. Barraco A, Rossi A, Nicolò G; EPHAR Study Group. Description of study population and analysis of factors influencing adherence in the observational Italian study 'Evaluation of Pharmacotherapy Adherence in Bipolar Disorder' (EPHAR). CNS Neurosci. Ther. 18(2), 110-118 (2012).
16. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Human psychopharmacology. Hum. Psychopharmacol. 23(2), 95-105 (2008).
17. Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann. Fam. Med. 6(1), 23-29 (2008).
18. Lang K, Korn J, Muser E, Choi JC, Abouzaid S, Menzin J. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics. J. Med. Econ. 14(2), 217-226 (2011).
19. Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr. Psychiatry 52(3), 280-287 (2011).
20. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr. Serv. 58(6), 855-863 (2007).
21. Sajatovic M, Blow FC, Kales HC, Valenstein M, Ganoczy D, Ignacio RV. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int. J. Geriatr. Psychiatry 22(10), 992-998 (2007).
22. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 8(3), 232-241 (2006).
23. Demyttenaere K, Adelin A, Patrick M, Walthère D, Katrien de B, Michèle S. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int. Clin. Psychopharmacol. 23(1), 36-42 (2008).
24. Shigemura J, Ogawa T, Yoshino A, Sato Y, Nomura S. Predictors of antidepressant adherence: results of a Japanese Internetbased survey. Psychiatry Clin. Neurosci. 64(2), 179-186 (2010).
25. Muzina DJ, Malone DA, Bhandari I, Lulic R, Baudisch R, Keene M. Rate of non-adherence prior to upward dose titration in previously stable antidepressant users. J. Affect. Disord. 130(1-2), 46-52 (2011).
26. Zivin K, Ganoczy D, Pfeiffer PN, Miller EM, Valenstein M. Antidepressant adherence after psychiatric hospitalization among VA patients with depression. Adm. Policy Ment. Health. 36(6), 406-415 (2009).
27. Sajatovic M, Elhaj O, Youngstrom EA et al. Treatment adherence in individuals with rapid cycling bipolar disorder: results from a clinical-trial setting. J. Clin. Psychopharmacol. 27(4), 412-414 (2007).
28. Wu CH, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res. Social Adm. Pharm. 8(3), 193-205 (2012).
29. Roca M, Armengol S, Salvador-Carulla L, Monzón S, Salvà J, Gili M. Adherence to medication in depressive patients. J. Clin. Psychopharmacol. 31(4), 541-543 (2011).
30. Sharma S, Kumar N, Chakraborti S, Sinha S, Kumari S, Gajendragad JM. Prevalence and factors associated with medication compliance in Indian patients suffering from mental disorders. Trop. Doct. 42(1), 28-31 (2012).
31. Herman S, Blumenthal JA, Babyak M, Khatri P, Craighead WE, Krishnan KR et al. Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. Health Psychol. 21(6), 553-563 (2002).
32. Munson MR, Floersch JE, Townsend L. Are health beliefs related to adherence among adolescents with mood disorders? Adm. Policy Ment. Health 37(5), 408-416 (2010).
33. Burra TA, Chen E, McIntyre RS, Grace SL, Blackmore ER, Stewart DE. Predictors of self-reported antidepressant adherence. Behav. Med. 32(4), 127-134 (2007).
34. Ten Doesschate MC, Bockting CL, Koeter MW, Schene AH. Predictors of nonadherence to continuation and maintenance antidepressant medication in patients with remitted recurrent depression. J. Clin. Psychiatry 70(1), 63-69 (2009).
35. Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 21(3), 121-125 (1988).
36. Sajatovic M, Micula-Gondek W, Tatsuoka C, Bialko C. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder. Gend. Med. 8(4), 261-268 (2011).
37. Scivoletto S, Silva TF, Cunha PJ, Rosenheck RA. The impact of psychiatric diagnosis on treatment adherence and duration among victimized children and adolescents in São Paulo, Brazil. Clinics (São Paulo) 67(1), 3-9 (2012).
38. Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 190(2-3), 253-258 (2011).
39. Perlis RH, Ostacher MJ, Miklowitz DJ et al. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. J. Clin. Psychiatry 71(3), 296-303 (2010).
40. Sajatovic M, Ignacio RV, West JA et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr. Psychiatry 50(2), 100-107 (2009).
41. Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J. Clin. Psychiatry 68(8), 1172-1176 (2007).
42. Weiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J. Clin. Psychiatry 59(4), 172-174 (1998).
43. Wolpe PR, Gorton G, Serota R, Sanford B. Predicting compliance of dual diagnosis inpatients with aftercare treatment. Hosp. Community Psychiatry 44(1), 45-49 (1993).
44. Goethe JW, Woolley SB, Cardoni AA, Woznicki BA, Piez DA. Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence. J. Clin. Psychopharmacol. 27(5), 451-458 (2007).
45. Agosti V, Quitkin FM, Stewart JW, McGrath PJ. Somatization as a predictor of medication discontinuation due to adverse events. Int. Clin. Psychopharmacol. 17(6), 311-314 (2002).
46. Holma IA, Holma KM, Melartin TK, Isometsä ET. Treatment attitudes and adherence of psychiatric patients with major depressive disorder: a five-year prospective study. J. Affect. Disord. 127(1-3), 102-112 (2010).
47. Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressantmedication compliance. Can. J. Psychiatry. 49(2), 106-113 (2004).
48. Liraud F, Verdoux H. Association between temperamental characteristics and medication adherence in subjects presenting with psychotic or mood disorders. Psychiatry Res. 102(1), 91-95 (2001).
49. Liu X, Tepper PG, Able SL. Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder. Int. Clin. Psychopharmacol. 26(3), 173-180 (2011).
50. Ayalon L, Areán PA, Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am. J. Geriatr. Psychiatry 13(7), 572-580 (2005).
51. Mackin RS, Areán PA. Cognitive and psychiatric predictors of medical treatment adherence among older adults in primary care clinics. Int. J. Geriatr. Psychiatry 22(1), 55-60 (2007).
52. Devulapalli KK, Ignacio RV, Weiden P, Cassidy KA, Williams TD, Safavi R et al. Why do persons with bipolar disorder stop their medication? Psychopharmacol. Bull. 43(3), 5-14 (2010).
53. Clatworthy J, Bowskill R, Rank T, Parham R, Horne R. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment. Bipolar Disord. 9(6), 656-664 (2007).
54. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R. Understanding medication non-adherence in bipolar disorders using a necessity-concerns frameworks. J. Affect. Disord. 116(1-2), 51-55 (2009).
55. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J. Clin. Psychiatry 63(5), 384-390 (2002).
56. Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J. Affect. Disord. 59(3), 237-241 (2000).
57. Scott J, Colom F, Pope M, Reinares M, Vieta E. The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders. J. Affect. Disord. 142(1-3), 72-76 (2012).
58. Ayuso-Mateos JL, Pereda A, Dunn G et al. Predictors of compliance with psychological interventions offered in the community. Psychol. Med. 37(5), 717-725 (2007).
59. Bambauer KZ, Soumerai SB, Adams AS, Zhang F, Ross-Degnan D. Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty. J. Clin. Psychiatry 68(6), 867-873 (2007).
60. Bagalman E, Yu-Isenberg KS, Durden E, Crivera C, Dirani R, Bunn WB 3rd. Indirect costs associated with nonadherence to treatment for bipolar disorder. J. Occup. Environ. Med. 52(5), 478-485 (2010).
61. Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry 22(1), 34-37 (1989).
62. Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr. Serv. 59(7), 753-759 (2008).
63. Gutiérrez-Rojas L, Jurado D, Martínez- Ortega JM, Gurpegui M. Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. J. Affect. Disord. 127(1-3), 77-83 (2010).
64. Yen CF, Lee Y, Tang TC, Yen JY, Ko CH, Chen CC. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders. J. Nerv. Ment. Dis. 197(3), 172-177 (2009).
65. Lin EH, Von Korff M, Katon W et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med. Care 33(1), 67-74 (1995).
66. Connelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch. Gen. Psychiatry 39(5), 585-588 (1982).
67. Keck PE Jr, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 155(5), 646-652 (1998).
68. Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? J. Psychosom. Res. 47(6), 491-495 (1999).
69. Brown C, Dunbar-Jacob J, Palenchar DR et al. Primary care patients' personal illness models for depression: a preliminary investigation. Fam. Pract. 18(3), 314-320 (2001).
70. Simons A, Lustman P, Wetzel R, Murphy G. Predicting response to cognitive therapy of depression, the role of learned resourcefulness. Cogn. Ther. Res. 9, 79-90 (1985).
71. Hung CI, Wang SJ, Liu CY, Hsu SC, Yang CH. Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder. Compr. Psychiatry 52(4), 370-377 (2011).
72. Bollini P, Tibaldi G, Testa C, Munizza C. Understanding treatment adherence in affective disorders: a qualitative study. J. Psychiatr. Ment. Health Nurs. 11(6), 668-674 (2004).
73. Toni C, Perugi G, Frare F et al. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry 33(4), 121-131 (2000).
74. Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J. Clin. Psychiatry 67(Suppl. 4), 14-21 (2006).
75. Nemeroff CB. New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum. Psychopharmacol. 17(Suppl. 1), S13-S16 (2002).
76. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19), 2511-2518 (1990).
77. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160(14), 2101-2107 (2000).
78. Tedlow JR, Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Rosenbaum JF. Are study dropouts different from completers? Biol. Psychiatry 40(7), 668-670 (1996).
79. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr. Serv. 52(12), 1615-1620 (2001).
80. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Association, Washington, DC, USA (1996).
81. Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. CNS Drugs 22(11), 963-973 (2008).
82. Lenze EJ. Comorbidity of depression and anxiety in the elderly. Curr. Psychiatry Rep. 5(1), 62-67 (2003).
83. Stein MB, Cantrell CR, Sokol MC, Eaddy MT, Shah MB. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatr. Serv. 57(5), 673-680 (2006).
84. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry 60(Suppl. 2), 77-84; discussion 111 (1999).
85. Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol. Psichiatr. Soc. 18(3), 179-183 (2009).
86. Martinez-Aran A, Scott J, Colom F et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J. Clin. Psychiatry 70(7), 1017-1023 (2009).
87. López-Jaramillo C, Lopera-Vásquez J, Gallo A et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 12(5), 557-567 (2010).
88. Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J. Affect. Disord. 149(1-3), 247-252 (2013).
89. Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De Las Cuevas C. Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies. Patient Prefer. Adherence 7, 151-169 (2013).